RedHill Biopharma (RDHL) Change in Inventory (2017 - 2022)
RedHill Biopharma (RDHL) posted quarterly Change in Inventory of $1.6 million for Q4 2022, up 192.87% year-over-year from $537789.4 in Q4 2021, and up 282.08% quarter-over-quarter from -$865000.0 in Q3 2022.
RedHill Biopharma (RDHL) Change in Inventory (2017 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Change in Inventory for 6 consecutive years, with $1.6 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Change in Inventory rose 192.87% year-over-year to $1.6 million; the TTM figure through Dec 2022 stood at $3.8 million (up 145.88% YoY), while the FY2025 annual figure was -$375000.0, down 150.81% from the prior year.
- Change in Inventory advanced to $1.6 million in Q4 2022 per RDHL's latest filing, from -$865000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $2.6 million in Q2 2022 and bottomed at -$4.4 million in Q3 2021.
- Historically, Change in Inventory has averaged -$517850.0 across 5 years, with a median of -$325000.0 in 2018.
- Annual changes were most pronounced in 2020 — Change in Inventory tumbled 1905.06% — and 2022, when it surged 403.55%.
- RedHill Biopharma's Change in Inventory stood at -$300000.0 in 2018, then soared by 126.33% to $79000.0 in 2019, then sank by 1905.06% to -$1.4 million in 2020, then retreated by 18.93% to -$1.7 million in 2021, then jumped by 192.87% to $1.6 million in 2022.
- Business Quant data shows RDHL's Change in Inventory at $1.6 million in Q4 2022, -$865000.0 in Q3 2022, and $2.6 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.58 Mn |
| Dec 31, 2022 | 1.58 Mn |
| Sep 30, 2022 | -865,000.00 |
| Sep 30, 2022 | -865,000.00 |
| Jun 30, 2022 | 2.55 Mn |
| Jun 30, 2022 | 2.55 Mn |
| Mar 31, 2022 | 538,000.00 |
| Mar 31, 2022 | 538,000.00 |
| Dec 31, 2021 | -1.70 Mn |
| Dec 31, 2021 | -1.70 Mn |
| Sep 30, 2021 | -4.35 Mn |
| Sep 30, 2021 | -4.35 Mn |
| Jun 30, 2021 | 507,000.00 |
| Jun 30, 2021 | 507,000.00 |
| Mar 31, 2021 | -2.74 Mn |
| Mar 31, 2021 | -2.74 Mn |
| Dec 31, 2020 | -1.43 Mn |
| Dec 31, 2020 | -1.43 Mn |
| Sep 30, 2020 | -350,000.00 |
| Sep 30, 2020 | -350,000.00 |